|
Video: What is a Stock Split?
|
|
Longeveron is a clinical stage biotechnology company developing cellular therapies for specific aging-related and life-threatening conditions. Co.'s primary investigational product is the LOMECEL-B cell-based therapy product, which is derived from culture-expanded medicinal signaling cells that are sourced from bone marrow of young healthy adult donors. Co. is sponsoring clinical trials in the following indications: Aging Frailty, Alzheimer's disease, the Metabolic Syndrome, Acute Respiratory Distress Syndrome, and hypoplastic left heart syndrome. According to our LGVN split history records, Longeveron has had 1 split. | |
|
Longeveron (LGVN) has 1 split in our LGVN split history database. The split for LGVN took place on March 27, 2024. This was a 1 for 10 reverse split, meaning for each 10 shares of LGVN owned pre-split, the shareholder now owned 1 share. For example, a 1000 share position pre-split, became a 100 share position following the split.
When a company such as Longeveron conducts a reverse share split, it is usually because shares have fallen to a lower per-share pricepoint than the company would like. This can be important because, for example, certain types of mutual funds might have a limit governing which stocks they may buy, based upon per-share price. The $5 and $10 pricepoints tend to be important in this regard. Stock exchanges also tend to look at per-share price, setting a lower limit for listing eligibility. So when a company does a reverse split, it is looking mathematically at the market capitalization before and after the reverse split takes place, and concluding that if the market capitilization remains stable, the reduced share count should result in a higher price per share.
Looking at the LGVN split history from start to finish, an original position size of 1000 shares would have turned into 100 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into Longeveron shares, starting with a $10,000 purchase of LGVN, presented on a split-history-adjusted basis factoring in the complete LGVN split history.
Growth of $10,000.00
Without Dividends Reinvested
|
Start date: |
02/16/2021 |
|
End date: |
04/26/2024 |
|
Start price/share: |
$75.10 |
|
End price/share: |
$1.75 |
|
Dividends collected/share: |
$0.00 |
|
Total return: |
-97.67% |
|
Average Annual Total Return: |
-69.23% |
|
Starting investment: |
$10,000.00 |
|
Ending investment: |
$233.14 |
|
Years: |
3.19 |
|
|
|
Date |
Ratio |
03/27/2024 | 1 for 10 |
|
|